76 Transplanting into Areas of Cicatricial Alopecia
Summary
Keywords: alopecia cicatricial lichen planopilaris frontal fibrosing alopecia unstable cicatricial alopecia stable cicatricial alopecia PRP fat grafting microneedling follicular family
Key Points
•Stable cicatricial alopecias are secondary to isolated events that cause permanent scarring in a hair-bearing region. Surgery can produce long-lasting excellent results.
•“Unstable” cicatricial alopecias are secondary to disorders that have a tendency to progress and recur intermittently over the course of time. Surgery should only be performed if the disease has been in remission for at least 2 years, and the patient remains on medical therapy and under medical surveillance.
•Surgery in an area of cicatricial alopecia needs to be performed with special regard for the vascular supply in the area. The size and density of sites may be limited and a second surgery is often necessary to achieve excellent cosmetic results.
•There are five interdependent factors to be respected when contemplating surgery for cicatricial alopecia: (1) the donor-to-recipient ratio over the patient’s lifetime, (2) scalp laxity, (3) the patient’s healing characteristics, (4) vascular supply, and (5) the location of the subsequent scar.
76.1 Introduction
Cicatricial alopecias are clearly on the rise. Hair restoration practices are seeing increasing numbers of patients with frontal fibrosing alopecia (FFA) and lichen planopilaris (LPP).1 These conditions, when active, are absolute contraindications to surgery. In some cases, quiescent cicatricial alopecias may be successfully treated with hair transplantation. Alternative approaches include medical treatment alone and alopecia reductions (ARs) and/or flap procedures, alone or together with hair transplanting. This chapter will be limited to a discussion of the techniques of hair transplantation and excision. The latter is, in fact, the preferable method of correction where appropriate. For purposes of clarity in this discussion, cicatricial alopecia will be referred to as “unstable” cicatricial alopecia (UCA) and “stable” cicatricial alopecia (SCA; Table 76.1).2 The distinction is extremely important with respect to the treatment choice and the possibility of surgical correction.
Stable cicatricial alopecia (SCA) | Unstable cicatricial alopecia (UCA) |
Trauma | Lymphocytic |
Burns cutaneous | Discoid lupus erythematosus |
Radiation-induced alopecia | Classic lichen planopilaris |
Prior hair transplantation | Frontal fibrosing alopecia |
Prior rhytidectomy and browlift | Graham–Little syndrome |
Traction alopecia | Classic pseudopelade (Brocq) |
Trichotillomania | Alopecia mucinosa |
Pressure alopecia | Keratosis follicularis spinulosa decalvans |
Congenital | Neutrophilic |
Aplasia cutis congenital | Folliculitis decalvans |
Lymphocytic | Dissecting folliculitis |
Central centrifugal cicatricial alopecia | Congenital |
Conradi–Hünermann chondrodysplasia punctate | |
Incontinentia pigmenti | |
Ankyloblepharon | |
Hallermann–Streiff syndrome | |
Generalized atrophic benign epidermolysis bullosa | |
Other | |
Acne keloidalis/acne necrotica | |
Erosive pustular dermatosis | |
Infection (deep fungal infections, zoster, massive bacterial folliculitis, tinea capitis with keratosis) | |
Metastatic/primary neoplasm | |
Graft vs. host disease |
Most dermatologists categorize alopecias as cicatricial or noncicatricial, and further distinction is made with regard to the type of inflammatory cells involved in the disease. Those who specialize in hair restoration surgery need a further type of categorization to help determine whether operative intervention will be of benefit. UCAs are secondary to disorders that have a tendency to progress and recur intermittently over the course of time. This is of particular importance currently, given the increase in incidence of both LPP and FFA. Additionally, the surgery itself may cause reactivation of the disease, and therefore it should only be considered after complete remission for a period of 2 years (previously, 1 year was thought to be sufficient).
If a hair transplant is performed knowing the patient has an UCA, the patient must understand the importance of continuing with medical surveillance and treatment—maintenance treatment may minimize or prevent recurrences. Case reports have been published showing disease reactivation within 6 years of hair transplantation if the patient is not on maintenance medical therapy.3 This is not a surprise. Patients need to be informed that if their disease becomes reactivated at any time, the success achieved with surgery would likely be compromised if the disorder is not promptly controlled (Box 76.1). It is possible to stop the insidious, intermittent progression of UCA with prompt appropriate medical therapy (see Chapter 9).
SCAs are secondary to isolated events that cause permanent scarring in a hair-bearing region. Surgery can produce excellent results in these cases and once successfully corrected there is no need for the constant vigilance that is required after treatment of UCA. Common inciting events resulting in SCA include trauma, burns, infection, radiation, and prior head and facial surgeries (Fig. 76.1).
Box 76.1
Unstable cicatrici alopecias (UCAs) should not be treated with hair transplant surgery unless the patient’s disease has been inactive for 2 years and medical surveillance and treatment is continued. If the disease reveals itself after surgery, prompt medical therapy can help preserve the hair.
76.2 Important Considerations in Surgical Correction
As noted earlier, because the cause of UCA can be expected to be intermittently recurrent, with subsequent cicatricial hair loss in new areas, excision is often the best choice for UCA provided the pattern and size of the scarring lend itself to that option (Fig. 76.2). However, the decision as to whether hair transplantation, excision, or “AR” should be utilized requires consideration of not only whether one is dealing with UCA or SCA but also five additional interdependent factors: (1) the donor-to-recipient ratio over the patient’s lifetime, (2) scalp laxity, (3) the patient’s healing characteristics, (4) vascular supply, and (5) the location of the subsequent scar (Box 76.2).